Pandey S, Smith B, Walker P R, Sikorska M
Apoptosis Research Group, Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario.
Apoptosis. 2000 Jun;5(3):265-75. doi: 10.1023/a:1009608630145.
The objective of this study was to establish whether apoptosis in 5123tc rat hepatoma cells required the caspase-3 dependent pathway. Apoptosis was induced by either growth factor deprivation or treatment with a topoisomerase II inhibitor, VM26, in the absence or presence of caspase inhibitors (DEVD-fmk, z-VAD-fmk and BAF). The results indicated that, although these inhibitors at 10 microM concentration completely blocked caspase-3 activity, they had no effect on either the rate of cell death or on any other apoptotic features, e.g., chromatin condensation, DNA fragmentation, protein cleavage, suggesting that caspase-3 was not required to mediate nuclear destruction in these hepatoma cells. At higher concentrations, up to 100 microM, z-VAD-fmk and BAF, but not DEVD-fmk, did block apoptosis, however, they also caused cell swelling and membrane permeabilization, which are the hallmarks of necrotic cell death. Clearly, high concentrations of these inhibitors must have interfered non-specifically with other metabolic pathways, e.g., z-VAD-fmk at a high concentration blocked protein phosphorylation, and caused cell death by a different mechanism.
本研究的目的是确定5123tc大鼠肝癌细胞中的凋亡是否需要半胱天冬酶-3依赖性途径。在存在或不存在半胱天冬酶抑制剂(DEVD-fmk、z-VAD-fmk和BAF)的情况下,通过生长因子剥夺或用拓扑异构酶II抑制剂VM26处理来诱导凋亡。结果表明,尽管这些抑制剂在10微摩尔浓度下完全阻断了半胱天冬酶-3的活性,但它们对细胞死亡速率或任何其他凋亡特征,如染色质浓缩、DNA片段化、蛋白质裂解均无影响,这表明在这些肝癌细胞中介导核破坏不需要半胱天冬酶-3。在高达100微摩尔的较高浓度下,z-VAD-fmk和BAF(而非DEVD-fmk)确实阻断了凋亡,然而,它们也导致细胞肿胀和膜通透性增加,这是坏死性细胞死亡的标志。显然,这些抑制剂的高浓度一定非特异性地干扰了其他代谢途径,例如高浓度的z-VAD-fmk阻断了蛋白质磷酸化,并通过不同机制导致细胞死亡。